Working Groups
Strategic Themes and their corresponding Working Groups
At the start of the ELBCC in 2018 we had defined Focus Areas centered around Stratetegic ILC Themes, which were further substantiated in Working Groups during the COST action LOBSTERPOT (CA19138). In February 2025 the Working Groups were extended into additional themes within ILC research. Working Groups (WGs) are headed by designated Scientists and Patient Advocates (PA)
Click on the WG scientists or patient advocate names for the designated WG page
WG1. Pathology
Anne Vincent-Salomon (Curie Institut)
Guiseppe Floris (KU Leuven)
Stuart Schnitt (Dana Farber)
Tone Lien (PA)
WG2. Functional Biology
Patrick Derksen (UMC Utrecht)
Chris Lord (ICR)
Claire Turner (PA, LBCUK)
WG3. Tumor Microenvironment
Fatima Mechta-Grigoriou (Curie Institut)
George Sflomos (EPFL)
Julia Houthuijzen (NKI-AvL)
Hélène Bonval (PA)
Lori Petitti (PA)
WG4. Imaging
Caroline Malhaire (Curie Institut)
Elleke Dresen (KU Leuven)
Lejla Cengic (PA)
Siobhán Freeney (PA)
WG5. Biomarkers of Metastatic ILC
Christine Desmedt (KU Leuven)
Amanda Fitzpatrick (Guy’s and St Thomas’ NHS Trust)
Silvia Knoll (PA)
Andrea Lener (PA)
WG6. Clinical Trials
Philippe Aftimos (Institute Jules Bordet)
Elinor Sawyer (King’s College)
Rachel Jankowitz (UPMC Hillman)
Rian Terveer-Couperus (PA, Lobulairborstkanker.nl)
Esther Geven (PA, Lobulairborstkanker.nl)
WG7. Education and Communication
Karen van Baelen (KU Leuven)
George Sflomos (EFPL)
Patrick Derksen (UMC Utrecht)
Andrea Lener (PA)
Claire Turner (PA, LBCUK)